Literature DB >> 2038952

Human immunodeficiency virus structure: implications for antiviral design.

E Arnold1, G F Arnold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2038952     DOI： 10.1016/s0065-3527(08)60792-7

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN： 0065-3527            Impact factor:   9.937


× No keyword cloud information.
  7 in total

1.  Crystals of a ternary complex of human immunodeficiency virus type 1 reverse transcriptase with a monoclonal antibody Fab fragment and double-stranded DNA diffract x-rays to 3.5-A resolution.

Authors:  A Jacobo-Molina; A D Clark; R L Williams; R G Nanni; P Clark; A L Ferris; S H Hughes; E Arnold
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 2.  Retroelements: propagation and adaptation.

Authors:  R Hull; S N Covey
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

3.  Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.

Authors:  J P Moore; J A McKeating; Y X Huang; A Ashkenazi; D D Ho
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

Review 4.  Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).

Authors:  E Sandström; B Oberg
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

5.  Macrophage-tropic and T-cell line-adapted chimeric strains of human immunodeficiency virus type 1 differ in their susceptibilities to neutralization by soluble CD4 at different temperatures.

Authors:  W A O'Brien; S H Mao; Y Cao; J P Moore
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

Review 6.  Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitor cells.

Authors:  M C Re; G Furlini; G Zauli; M La Placa
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

7.  Domain structure of the human immunodeficiency virus reverse transcriptase.

Authors:  H Lederer; O Schatz; R May; H Crespi; J L Darlix; S F Le Grice; H Heumann
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.